|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer.
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:class
|
A61K
|
|
gptkbp:clinicalTrials
|
NCT01234567
|
|
gptkbp:contains
|
active pharmaceutical ingredient
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
September 7, 2024
|
|
gptkbp:fieldOfInvention
|
pharmaceutical compositions
|
|
gptkbp:fieldOfUse
|
oncology
|
|
gptkbp:filedIn
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:filingDate
|
March 15, 2002
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,081 C-7
|
|
gptkbp:internationalClassification
|
C07D
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
|
gptkbp:issuedOn
|
September 7, 2004
|
|
gptkbp:legalStatus
|
patent granted
|
|
gptkbp:marketedAs
|
BrandName Drug
|
|
gptkbp:patentExpiration
|
2024-09-07
|
|
gptkbp:patentFamily
|
US_6,789,081_C-7_family
|
|
gptkbp:patentLitigation
|
none
|
|
gptkbp:patentNumber
|
6,789,081
|
|
gptkbp:patentOwner
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:research_areas
|
oncology
|
|
gptkbp:researchField
|
biotechnology
|
|
gptkbp:status
|
active
|
|
gptkbp:subclass
|
A61P
|
|
gptkbp:technology
|
drug formulation
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|